News Cover
Opinion

Looking at ‘repurposing’ medication: Biocon

Bengaluru-based biotech main Biocon is engaged on a number of fronts — therapeutic vaccines, new medication and ‘repurposing’ medicines — to deal with the Covid-19 pandemic. The firm, with revenues of over Rs 5,600 crore, hopes to “repurpose” its present novel biologic Itolizumab to deal with issues brought on by Covid-19, whereas one other drug Cytosorb, used for sepsis remedy, may additionally assist in decreasing mortality, its chairperson Kiran Mazumdar-Shaw stated. Biocon is exploring alternatives to collaborate with US firms to develop antibody-based therapeutic vaccines by way of Indian-American oncologist Siddhartha Mukherjee, she informed TOI. Excerpts:

Several pharma firms are utilizing present medication to see in the event that they work for Covid-19. Is Biocon “repurposing” medication from its portfolio?

We are working to repurpose our novel monoclonal antibody Itolizumab (utilized in psoriasis) to deal with issues brought on by Covid-19 an infection. If we are able to efficiently set up the potential function for our molecule in treating Covid-19 issues, it’ll allow us to deal with a crucial unmet want.

In addition, Cytosorb, a product that Biocon has licensed from a US firm, has not too long ago been authorized by the USFDA for emergency remedy of Covid-19. Cytosorb — launched in India for sepsis remedy in 2013 — is a secure and well-tolerated progressive remedy for managing cytokine storm in critically-ill sufferers. We hope that it’ll assist in bringing down mortality in Covid-19 sufferers as effectively.

Biocon is known to have partnered famous oncologist Siddhartha Mukherjee for creating Covid-19 medication. Are these plasma-derived therapies or anti-virals?

By way ofMukherjee, we’re in touch with a number of US firms creating antibody-based therapeutic vaccines. We wish to discover alternatives to collaborate with these US firms to develop these antibody-based vaccines collectively. There is not any formal tie-up as but.

What is the standing of check kits which Biocon’s subsidiary Syngene is creating? Are these antibody testing kits or PCR ones?

At Syngene, my crew is engaged on creating PCR-based diagnostic in addition to a serological antibody testing kits. Serological testing can be utilized to detect antibodies current within the blood to determine the true variety of individuals in a inhabitants who’ve are available contact with the Covid-19 virus.

This check can really additionally determine individuals who might not even have proven any signs and recovered. If serologic testing could be completed on a lot of individuals throughout the nation, it might additionally reveal if India as a rustic has developed ‘herd immunity’ towards the illness, it’ll give the federal government a key information matrix to steadily raise curfews lockdown from particular areas.

Related posts

Leave a Comment